CME/CE

113-128 of 194

• 

  MinuteCE®

  HER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management

  Carey Anders, MD, FASCO; Sarah Sammons, MD

  1.00 credit 10 episodes

  • 

    

    Carey Anders, MD, FASCO

  • 

    

    Sarah Sammons, MD

  1.00 credit 10 episodes

• 

  RestartResume

  Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer

  RestartResume

  Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer

  MinuteCE®

  Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer

  Carey Anders, MD, FASCO; Sarah Sammons, MD

  1.00 program credit

  • 

    

    Carey Anders, MD, FASCO

  • 

    

    Sarah Sammons, MD

  1.00 program credit

• 

  RestartResume

  HER2-Targeted TKI Combinations in Second-Line and Beyond MBC 

  RestartResume

  HER2-Targeted TKI Combinations in Second-Line and Beyond MBC 

  MinuteCE®

  HER2-Targeted TKI Combinations in Second-Line and Beyond MBC 

  Sarah Sammons, MD

  1.00 program credit

  • 

    

    Sarah Sammons, MD

  1.00 program credit

• 

  RestartResume

  Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC

  RestartResume

  Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC

  MinuteCE®

  Sequencing Strategies for Second-Line and Beyond Treatment of HER2+ MBC

  Sarah Sammons, MD; Carey Anders, MD, FASCO

  1.00 program credit

  • 

    

    Sarah Sammons, MD

  • 

    

    Carey Anders, MD, FASCO

  1.00 program credit

• 

  RestartResume

  Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches

  RestartResume

  Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches

  MinuteCE®

  Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches

  Carey Anders, MD, FASCO

  1.00 program credit

  • 

    

    Carey Anders, MD, FASCO

  1.00 program credit

• 

  RestartResume

  Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer

  RestartResume

  Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer

  MinuteCE®

  Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer

  Sarah Sammons, MD

  1.00 program credit

  • 

    

    Sarah Sammons, MD

  1.00 program credit

• 

  RestartResume

  Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care

  RestartResume

  Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care

  CME/CE

  Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care

  Heather McArthur, MD, MPH, FASCO; Margaret Gatti-Mays, MD, MPH

  0.25 credits

  • 

    

    Heather McArthur, MD, MPH, FASCO

  • 

    

    Margaret Gatti-Mays, MD, MPH

  0.25 credits

• 

  RestartResume

  Right Heart Catheterization: Mastery of Precision Techniques

  RestartResume

  Right Heart Catheterization: Mastery of Precision Techniques

  CME/CE Broadcast Replay

  Right Heart Catheterization: Mastery of Precision Techniques

  Richard Krasuski, MD; Vallerie V. McLaughlin, MD

  1.00 credit

  • 

    

    Richard Krasuski, MD

  • 

    

    Vallerie V. McLaughlin, MD

  1.00 credit

• 

  RestartResume

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  RestartResume

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  CME/CE Broadcast Replay

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  Robert P. Frantz, MD, FACC; Vallerie V. McLaughlin, MD

  1.00 credit

  • 

    

    Robert P. Frantz, MD, FACC

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Sonja Bartolomei, MD

  1.00 credit

• 

  RestartResume

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  RestartResume

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  CME/CE Broadcast Replay

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  Vallerie V. McLaughlin, MD; Thomas Cascino, MD

  1.00 credit

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Thomas Cascino, MD

  • 

    

    Bradley A. Maron, MD

  1.00 credit

• 

  RestartResume

  Pulmonary Hypertension Management: Practice Trends and Updates

  RestartResume

  Pulmonary Hypertension Management: Practice Trends and Updates

  CME/CE Broadcast Replay

  Pulmonary Hypertension Management: Practice Trends and Updates

  Vallerie V. McLaughlin, MD; Victor Moles, MD

  1.00 credit

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Victor Moles, MD

  • 

    

    Ioana Preston, MD

  1.00 credit

• 

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  RestartResume

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  MinuteCE®

  Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment

  Nicholas J. Silvestri, MD; Jeffrey Allen, MD

  1.00 program credit

  • 

    

    Nicholas J. Silvestri, MD

  • 

    

    Jeffrey Allen, MD

  1.00 program credit

• 

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  RestartResume

  Novel Mechanisms of Action: FcRn Inhibitors

  MinuteCE®

  Novel Mechanisms of Action: FcRn Inhibitors

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  RestartResume

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  MinuteCE®

  Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit

• 

  RestartResume

  Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs

  RestartResume

  Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs

  MinuteCE®

  Interprofessional Monitoring and Management of AEs With HER3-Directed ADCs

  Helena Yu, MD; Pasi Antero Jänne, MD, PhD

  0.75 program credits

  • 

    

    Helena Yu, MD

  • 

    

    Pasi Antero Jänne, MD, PhD

  0.75 program credits

• 

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  RestartResume

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  MinuteCE®

  Autoantibodies in CIDP: Prevalence and Diagnostic Implications

  Jeffrey Allen, MD; Nicholas J. Silvestri, MD

  1.00 program credit

  • 

    

    Jeffrey Allen, MD

  • 

    

    Nicholas J. Silvestri, MD

  1.00 program credit